Cell Therapeutics (CTIC) Pixantrone NDA Meeting Delayed by U.S. FDA Due to Inclement Waether
Tweet Send to a Friend
Cell Therapeutics, Inc. (NASDAQ: CTIC) announced today that the United States Food and Drug Administration (the "FDA") informed CTI that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
